Streetbeat News

Price Targets

YETI

Raymond James analyst Joseph Altobello has maintained an Outperform rating on YETI Holdings and raised the price target from $48 to $55.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 12:25 pm

SLGL

Raymond James analyst Elliot Wilbur has maintained a 'Strong Buy' rating on Sol-Gel Technologies (NASDAQ:SLGL), but lowered the price target from $9 to $7.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 12:24 pm

MAXN

Raymond James analyst Pavel Molchanov maintains an Outperform rating on Maxeon Solar Technologies (NASDAQ:MAXN) but has lowered the price target from $34 to $28.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 12:23 pm

KGS

Raymond James analyst James Rollyson has maintained an 'Outperform' rating on Kodiak Gas Services (NYSE:KGS) and raised the price target from $21 to $23.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 12:23 pm

STGW

Goldman Sachs analyst Brett Feldman has maintained a 'Buy' rating on Stagwell (NASDAQ:STGW) but lowered the price target from $12 to $9.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 12:22 pm

HLLY

Raymond James analyst Joseph Altobello has maintained an 'Outperform' rating on Holley (NYSE:HLLY) and raised the price target from $6.25 to $8.25.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 12:22 pm

RBLX

Canaccord Genuity analyst Jason Tilchen has maintained a 'Buy' rating on Roblox (NYSE:RBLX), but lowered the price target from $48 to $42.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 11, 2023 | 12:22 pm

FBRT

Raymond James analyst Stephen Laws maintains an Outperform rating on Franklin BSP Realty Trust (NYSE:FBRT) and raises the price target from $14.5 to $15.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 12:21 pm

SONX

Goldman Sachs analyst Nathan Rich has maintained a 'Buy' rating on Sonendo (NYSE:SONX), but lowered the price target from $2 to $1.75.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 12:21 pm

TPST

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Tempest Therapeutics (NASDAQ:TPST) and maintained a price target of $35.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 12:20 pm